|
|
Parkinson’s Disease " Updates in Diagnosis and Patient Management
Parkinson's disease is a neurodegenerative disorder, second only in prevalence to Alzheimer’s disease. Numerous therapeutic options, including carbidopa/levodopa, monoamine oxidase-B inhibitors, dopamine agonists, and device-assisted therapies, are available for treatment. These treatments are indicated at different stages following diagnosis. However, Parkinson’s disease progresses at highly variable rates, and no biomarkers, laboratory tests, or gold standard indexes are available t... |
|
|
Evidence Based Cognitive Communication Treatment-Parkinsons Patients - Aimee Mooney, MS, CCC-SLP
Parkinsons Disease is a chronic and progressive neurodegenerative disease that affects 1.5 million people with an additional 60,000 new diagnoses made annually. Over 85 percent of the diagnoses are made in individuals over age 50. With the Baby Boomers increasing in age, Speech and Language Pathologists need to be ready to treat this population.
The presentation of the disease is individualized and multifaceted, including both motor and non motor symptoms. It is unpredictable and complex, ... |
|
|
Maximizing Outcomes in Patients with Cognitive Impairments - Dr. Robert Winningham
Patients with cognitive impairment often have difficulty with functional activities as well as learning or relearning behaviors in the clinic. Many clients are functioning below their potential, because of fear or other psychological barriers. In addition, depressed, unmotivated, apathetic and/or anxious clients often do not benefit from treatment as much as others. As you know, these patients often pose difficult challenges for therapists. In this exciting and unique 2 day course, we will lea... |
|